Search:

Home Index Back issues Contact

 

Volume 1, Number 4

 

Early diagnosis of lung cancer using bronchoscopy

Joanna L Brown MD MRCP Respiratory Department, Portsmouth Hospitals NHS Trust; Jeremy M George MD FRCP Department of Thoracic Medicine, University College London Hospitals NHS Trust

Lung cancer accounts for more deaths than any other malignancy in both men and women in the UK. Despite advances in diagnosis, staging and treatment, survival rates for patients remain extremely poor. Follow-up studies of patients diagnosed between 1993 and 1995 in England showed a median survival of only 22% at one year and 5.5% at five years.1

 

Clinical studies round-up

Richard Stephens, Research Scientist responsible for the Medical Research Council Clinical Trials Unit’s portfolio of lung cancer trials.

In this issue we complete a four-part look at current and new National Cancer Research Institute randomised lung cancer trials.

 

The earlier detection of lung cancer

Michael D Peake, Editor

One of the major handicaps that we face in the management of patients with lung cancer is that they do not usually present to medical services until very late in the natural history of their disease. The contrast between an ‘internalised’ tumour in lung cancer and breast cancer, where a pea-sized tumour can often be palpated by otherwise totally symptom-free women, is stark and requires more complex detection strategies.

 

Specialist lung cancer nurses

Jesme Baird MB CHB MBA Director of Patient Care, The Roy Castle Lung Cancer Foundation

When The Roy Castle Lung Cancer Foundation (RCLCF) began its patient care work in 1998, it found around 20 UK nurses specialising in lung cancer. On discussion with patients, it was clear that those who had accessed this professional group benefited enormously.

 

Overview of quality of life assessment in lung cancer patients

Pauline Leonard RGN MBBS(Hons) MRCP Consultant Medical Oncologist, Southend Hospital Cancer Centre

Quality of life (QoL) is increasingly recognised as an important factor when measuring the impact of treatments in cancer management.

 

Patient experience of surgery for non-small cell lung cancer

Nicola Bell BSc(Hons) Lung Cancer Nurse Specialist, Harrogate Health Care NHS Trust, North Yorkshire

The best chance of cure for lung cancer lies with surgery but less than 10% of patients in the UK have lung resections – largely due to late presentation, an elderly patient population and co-morbidity.1

 

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Lung Cancer in Practice is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk